Literature DB >> 22787223

Protective capacity of virus-specific T cell receptor-transduced CD8 T cells in vivo.

Katja Mueller1, Anne von Mässenhausen, Ulrike Aichele, Lilian Stärck, Matthias Leisegang, Wolfgang Uckert, Hanspeter Pircher.   

Abstract

The transfer of T cell receptor (TCR) genes by viral vectors represents a promising technique to generate antigen-specific T cells for adoptive immunotherapy. TCR-transduced T cells specific for infectious pathogens have been described, but their protective function in vivo has not yet been examined. Here, we demonstrate that CD8 T cells transduced with the P14 TCR specific for the gp33 epitope of lymphocytic choriomeningitis virus exhibit protective activities in both viral and bacterial infection models in mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22787223      PMCID: PMC3457306          DOI: 10.1128/JVI.01472-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Antigen-specific CD8+ T cells respond to Chlamydia trachomatis in the genital mucosa.

Authors:  Nadia R Roan; Michael N Starnbach
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Recall proliferation potential of memory CD8+ T cells and antiviral protection.

Authors:  Martin F Bachmann; Petra Wolint; Katrin Schwarz; Annette Oxenius
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

3.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo.

Authors:  H Pircher; D Moskophidis; U Rohrer; K Bürki; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

Review 4.  TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008.

Authors:  Wolfgang Uckert; Ton N M Schumacher
Journal:  Cancer Immunol Immunother       Date:  2009-02-03       Impact factor: 6.968

5.  CMV-specific TCR-transgenic T cells for immunotherapy.

Authors:  Andrea Schub; Ingrid G Schuster; Wolfgang Hammerschmidt; Andreas Moosmann
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

6.  Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.

Authors:  Gavin M Bendle; Carsten Linnemann; Anna I Hooijkaas; Laura Bies; Moniek A de Witte; Annelies Jorritsma; Andrew D M Kaiser; Nadine Pouw; Reno Debets; Elisa Kieback; Wolfgang Uckert; Ji-Ying Song; John B A G Haanen; Ton N M Schumacher
Journal:  Nat Med       Date:  2010-04-18       Impact factor: 53.440

7.  Reconstitution of anti-HIV effector functions of primary human CD8 T lymphocytes by transfer of HIV-specific alphabeta TCR genes.

Authors:  Takamasa Ueno; Mamoru Fujiwara; Hiroko Tomiyama; Masafumi Onodera; Masafumi Takiguchi
Journal:  Eur J Immunol       Date:  2004-12       Impact factor: 5.532

8.  Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates.

Authors:  M Battegay; S Cooper; A Althage; J Bänziger; H Hengartner; R M Zinkernagel
Journal:  J Virol Methods       Date:  1991-06       Impact factor: 2.014

9.  Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette.

Authors:  Matthias Leisegang; Boris Engels; Peter Meyerhuber; Elisa Kieback; Daniel Sommermeyer; Shao-An Xue; Simone Reuss; Hans Stauss; Wolfgang Uckert
Journal:  J Mol Med (Berl)       Date:  2008-03-12       Impact factor: 4.599

10.  Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.

Authors:  Aviva Joseph; Jian Hua Zheng; Antonia Follenzi; Teresa Dilorenzo; Kaori Sango; Jaime Hyman; Ken Chen; Alicja Piechocka-Trocha; Christian Brander; Erik Hooijberg; Dario A Vignali; Bruce D Walker; Harris Goldstein
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

View more
  3 in total

1.  Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.

Authors:  Janine Kah; Sarene Koh; Tassilo Volz; Erica Ceccarello; Lena Allweiss; Marc Lütgehetmann; Antonio Bertoletti; Maura Dandri
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 2.  Updates on Chronic HBV: Current Challenges and Future Goals.

Authors:  Hannah M Lee; Bubu A Banini
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

3.  PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.

Authors:  Felicitas Rataj; Fabian B T Kraus; Michael Chaloupka; Simon Grassmann; Constanze Heise; Bruno L Cadilha; Peter Duewell; Stefan Endres; Sebastian Kobold
Journal:  Front Immunol       Date:  2018-08-30       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.